New Strategy to Quantify Hepatic CYP3A Activity with Deoxyschizandrin as an In Vivo Probe: A V Approach

Key Points

• CYP3A activity quantification was successfully achieved using deoxyschizandrin as a probe, enhancing assessment of drug metabolism in the liver.
• The probe effectively demonstrated its utility, with results indicating potential applications in personalized medicine for drug safety and efficacy.
• Researchers utilized in vivo methods in their analysis, applying a novel approach that may lead to improved metabolic profiling techniques.
• This study highlights new opportunities for drug development, but further validation in diverse populations is needed for broader applicability.